Blog
Gene Therapy Research: Past, Present, Future
Gene Therapy Research: Past, Present, Future By: Joanna Wirkus Gene Therapy: Where We’ve Been: The Human Genome Project concluded in 2003 after 13 years of effort aimed at mapping the entire Human Genome and improving DNA sequencing technology at large. This milestone set the foundation for a better understanding of the drivers of disease…
For More InformationOvercoming Challenges with Animal Models in Research
Overcoming Challenges with Animal Models in Research – How Starting With the Right Cells Can Improve Science That Saves Lives BY JOANNA WIRKUS One estimate reports that more than 100 million mice are used in biomedical research each year in the U.S. Mus musculus, the most common model organism, has been the foundation of biological…
For More InformationEIN Presswire: CGT Global Receives Approval Aiding Scientists in Discovering Life-Saving Cures
CGT Global, a leading Contract Research Organization (CRO) & biotech manufacturer announced approval to provide disease state leukopaks to researchers worldwide FOLSOM, CALIFORNIA, UNITED STATES, June 11, 2024 /EINPresswire.com/ — CGT Global, a leading international Contract Research Organization (CRO) and biotech manufacturer, announced today it has received approval from Western Copernus Group (WCG) to provide disease…
For More InformationEIN Presswire: CGT Global and Austin Financial Partner to Drive Momentum for Cutting-Edge Cell Therapy Treatments and Cures
CGT Global, leader in human cell collection, partners with Austin Financial Services to expedite cell & gene therapy research for life-threatening conditions. FOLSOM, CALIFORNIA, USA, March 20, 2024 /EINPresswire.com/ — A world leader in human cell collection and manufacturing, CGT Global announced today it is partnering with Austin Financial Services, Inc., a leading national middle…
For More InformationEIN Presswire: CGT Global Selected as Strategic Partner to Expand Cell and Gene Therapies Across the United States
FOLSOM, CA, UNITED STATES, December 6, 2023 /EINPresswire.com/ — CGT GLOBAL, a company dedicated to expanding access and scalability of cell and gene therapies, has announced a major collaboration with global company Orgenesis (NASDAQ: ORGS) through its subsidiary Octomera. Orgenesis has 60 cell and gene therapy mobile laboratories currently deployed in Europe and Asia. CGT Global…
For More InformationKFBK & NPR Interviews with CGT Global
THE FUTURE OF HEALTHCARE Our own Cate Spears, CEO and founder of CGT Global, was just interviewed on two major news media outlets. Nationally recognized broadcaster Cristina Mendosa from KFBK and Vicki Gonzales from NPR‘s CapRadio. Both interviews discuss our innovative collaboration to deliver cell and gene therapies across the globe. LISTEN NOW We encourage…
For More InformationTop-Tier Quality
TOP-TIER QUALITY Biotechnology is a rapidly evolving industry which has the potential to revolutionize the Healthcare field. As the biotechnology industry continues to advance ensuring the safety, efficacy and quality of the products and processes are maintained at every step becomes critical to everyone in the field. This is where CGT Global plays a pivotal…
For More InformationMeet our Laboratory Team
CGT Global is thrilled to introduce you to the incredible members of our laboratory team who make the magic happen every day. Bryan: The Fearless Leader With an analytical mind and a passion for innovation, Bryan spearheads our lab projects, ensuring precision and excellence in every isolation and custom project. Eliona: The Scientist Eliona’s infectious…
For More InformationCGT Global Launches CellsExpress Bulk Cell Isolation
StemExpress Launches CellsExpress Bulk Cell Isolation Researchers can maximize their isolated cell output, saving valuable time and budget better spent on their research. FOLSOM, Calif. , /PRNewswire/ — As a trusted provider of high-quality isolated human stem and immune cells for over a decade, StemExpress is now proud to offer select isolated products in bulk…
For More InformationAARC Annual Meeting 2022
March 11, 2022 (NEW ORLEANS, LA) – StemExpress is excited to attend the AACR Annual Meeting, April 8-13, 2022, where we will join the innovative minds in the clinical space to discuss the importance of picking partners from product development to clinical commercialization. As more cancer therapies move through clinical approval, our company mission is…
For More Information